Amgen plans expansion at DuBiotech
Dubai, August 22, 2009
Dubai Biotechnology and Research Park (DuBiotech), a life sciences hub, said Amgen International, a top biotechnology company, discussed expansion plans during a meeting of senior management members.
Discussing Amgen’s future plans at the biotech park and the potential of expanding regional presence, Rolf Hoffman, senior vice president - commercial operations, Amgen International, expressed interest in clinical research, and developing clinical trials in collaboration with DuBiotech and clinical research organizations (CROs).
Amgen is also exploring the possibility of developing a logistics centre in DuBiotech that is connected to its main logistics platform in Europe to serve the entire Middle East and African markets from Dubai.
Dr Marco Baccanti, executive director of DuBiotech, said: “We feel privileged that the development strategy of DuBiotech is facilitating Amgen’s regional expansion plans. The biotechnology cluster gains significance from the infrastructure point of view because of its laboratories, warehouses and offices.
“Its cluster composition with the presence of pharmaceutical companies, research institutions, CROs, and strong affiliations with the UAE Ministry of Health and local health authorities, further serve as strong incentives for companies seeking a presence in the region,” he added.
“Amgen is one of the founding members of the DuBiotech community and its operations enrich the biotechnology sector in the region, in addition to contributing to its growth.”
Ashraf Allam, regional managing director of Amgen, said: “Our goal is to become the best human therapeutics company in this part of the world. In an area with a population of over half billion people, there is immense potential for Amgen to serve a range of patients.
“We chose the park as an ideal location to accommodate the entire life sciences value chain. It provides key facilities and incorporates specially tailored amenities to support the rigorous requirements of research and development, manufacturing, distribution and high value-added services.”
Amgen was one of the first biotech companies to establish operations in the Middle East. Founded in 2006, Amgen’s local organisation has since launched activities in several countries in the Middle East, as well as Turkey and South Africa. The headquarters for Amgen’s MEAT (Middle East, Africa and Turkey) operations is located at the Dubai Biotechnology and Research Park.
Amgen’s Dubai office acts as the regional hub for the Middle East, Africa and Turkey for commercial and medical activities, providing all functional and management support to the region including marketing, medical, finance, supply chain and regulatory affairs.
Currently, DuBiotech hosts some of the world's top pharmaceutical/biotechnology companies such as Pfizer, Genzyme and Merck Serono, and has firmly established itself as a globally recognized centre for the life science industries. – TradeArabia News Service
More Health & Environment Stories
- Bapco installs $120m water treatment plant
- $68bn health bill warning for GCC
- VLCC launches anti-obesity initiative in Bahrain
- 1,000 health experts at Doha innovation summit
- Major progress in fight against malaria
- MAF Dalkia, Dubai Aviation ink consultancy deal
- Summit highlights HR challenges in Arab health sector
- Saudi launches ambitious gene mapping project
- ADSW to focus on energy-water nexus
- Bahrain moves to combat marine pollution